-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/updating-treatments-fecal-incontinence-viii
March 31, 2021 - We would like to see all evidence of NASHA/Dx FI's safety and effectiveness considered, including: … Real-world safety, efficacy, and medical appropriateness of NASHA/Dx FI
Significant improvements in … objective clinical measures, re-intervention rate (>80% of patients treated do not require re-intervention … We will use the updated guideline primarily to educate physicians, patients, and third-party payers with … Patient Advocate
May we contact you if we have questions about your nomination? No
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/update-treatments-fecal-incontinence
March 15, 2021 - et al., 2016 Publication: Analyzed & highlighted the benefit of NASHA/Dx FI vs Sham in specific key patient … NASHA/Dx FIPost Approval Study (PAS), 2020: 283-patient, 36-month, multi-center PAS with robust long-term … NASHA/Dx FI
Significant improvements in objective clinical measures, re-intervention rate (>80% of patients … To educate physicians, patients, and third-party payers with respect to the current state of evidence … Physician and researcher actively engaged in looking after patients, advocating for them, and doing clinical
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-205-predictors-trauma-care-evidence-summary.pdf
April 01, 2018 - and
Quality in conjunction with the sponsoring partner
agency, the National Highway Transportation Safety … If the indicators of high-risk patients were
consistent, cleaner comparisons could be made both across … Washington, DC:
National Highway Traffic Safety Administration; February 2013. … Prehospital triage in
the injured pediatric patient. … Decision tool for the
early diagnosis of trauma patient hypovolemia.
-
effectivehealthcare.ahrq.gov/products/safety-vaccines/protocol
April 06, 2020 - Meta-regressions will add patient variables (age, gender, race/ethnicity, genotype, underlying medical … Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory … Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes … Efficacy and Safety of Vaccination in Pediatric Patients with Systemic Inflammatory Rheumatic Diseases … Efficacy and Safety of Vaccination in Pediatric Patients with Systemic Inflammatory Rheumatic Diseases
-
effectivehealthcare.ahrq.gov/products/instrumental-variable-methods/research
May 14, 2010 - Instrumental Variable Methods in Comparative Safety and Effectiveness Research
Research Report May … Similarly, one could assess safety in these same patients by exploring the association between formulary … In some cases, the concept of a "marginal patient" may be problematic as individual patients may be marginal … Distance must also not be related to patient characteristics. … first-stage regression, in particular the partial r-squared value and the first-stage F statistic, both indicators
-
effectivehealthcare.ahrq.gov/products/diabetes-claims-data/research
April 07, 2010 - We used this review to determine which glycemic indicators should be assessed to determine the adequacy … We used the patient problem, laboratory test, medication prescribing, and transcription files to identify … In both patient cohorts, we described comorbidities present when DMT2 was diagnosed and medications used … Conclusions
By conducting similar analyses in both patient populations, we could discern the value … Text-mining methods may be useful for ascertaining information critical to research studies and drug safety
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/updating-treatments-fecal-incontinence-ix
March 15, 2021 - et al., 2016 Publication: Analyzed & highlighted the benefit of NASHA/Dx FI vs Sham in specific key patient … NASHA/Dx FIPost Approval Study (PAS), 2020: 283-patient, 36-month, multi-center PAS with robust long-term … NASHA/Dx FI
Significant improvements in objective clinical measures, re-intervention rate (>80% of patients … I will use the updated guideline primarily to educate physicians, patients, and third-party payers with … Patient Advocate
May we contact you if we have questions about your nomination? No
-
effectivehealthcare.ahrq.gov/products/public-reporting-cost-measures/research-protocol
January 13, 2014 - Traditionally, indicators related to the quality of healthcare are measured through various indicators … Yegian JM, Dardess P, Shannon M, Carman KL. (2013) Engaged patients will need comparative physician-level … They may include clinical experts, patients, manufacturers, researchers, payers, or other perspectives … Connecticut Hospital Association
Connecticut
Hospital
http://www.cthosp.org/advocacy/quality-and-patient-safety … //myvbch.org/about-vbch/f acilities/report-cards/
Washington State Hospital Association - Quality Indicators
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-infection-prevention-mdro-protocol.pdf
July 01, 2023 - What patient safety measures or indicators have been used to examine the frequency and severity of … What patient safety practices have been used to prevent or mitigate the harms of healthcare-associated … What are the most common barriers and facilitators of implementing the patient safety practices? … What toolkits are available to support implementation of the patient safety practices? … stakeholders, clinical specialists,
experts in patient safety issues, and a patient/consumer perspective
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/update-treatments-fecal-incontinence-ii
March 15, 2021 - We would like to see all evidence of NASHA/Dx FI's safety and effectiveness considered, including: … et al., 2016 Publication: Analyzed & highlighted the benefit of NASHA/Dx FI vs Sham in specific key patient … NASHA/Dx FIPost Approval Study (PAS), 2020: 283-patient, 36-month, multi-center PAS with robust long-term … NASHA/Dx FI
Significant improvements in objective clinical measures, re-intervention rate (>80% of patients … We will use the updated guideline primarily to educate physicians, patients, and third-party payers with
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-prognostic_methods.pdf
July 01, 2012 - How were previously established prognostic indicators or other prognostic assessments included in the … Were any previously established prognostic indicators or prediction models being used as comparators … Reviewers need to be aware of any previously established prognostic indicators
that should be included … • A large number of published reports focus on the associations between prognostic
indicators and … Efficacy and safety of quinidine therapy for
maintenance of sinus rhythm after
cardioversion.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-pain_research-protocol.pdf
August 05, 2010 - Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness and Safety … In addition,
efficacy and safety may vary for individual drugs within a class. … We will also
include studies that report safety in patients with rheumatoid arthritis or were taking … ; setting (primary care or referral); the number of patients randomized relative to
the number of patients … Comparative effectiveness
and safety of analgesics for osteoarthritis.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/updating-treatments-fecal-incontinence-vi
March 15, 2021 - I also note that important long-term data documenting treatment impact on patients' reported health-related … et al., 2016 Publication: Analyzed & highlighted the benefit of NASHA/Dx FI vs Sham in specific key patient … NASHA/Dx FIPost Approval Study (PAS), 2020: 283-patient, 36-month, multi-center PAS with robust long-term … improvements in objective clinical measures, re-intervention rate (>80% of patients treated do not require … We will use the updated guideline primarily to educate physicians, patients, and third-party payers with
-
effectivehealthcare.ahrq.gov/products/off-label-use-research-priorities/research
June 29, 2009 - Notably, while raising some concerns about off-label use, the studies also identify disease- and patient-specific … Three prior studies have examined off-label use among broader, more representative patient populations … physician survey that provides nationally representative diagnostic and prescribing information on patients … insure that the most common drugs dispensed through pharmacies matched those reported by physicians at patient … Regulatory and reimbursement issues in treating patients with immune-mediated neuropathies.
-
effectivehealthcare.ahrq.gov/products/type-2-diabetes-insulin/research
September 15, 2008 - Timeline Jan. 1, 2005 Topic Initiated Sep. 15, 2008 Systematic Review Comparative Effectiveness, Safety … Clinicians may be better able to choose the most effective therapy for their patients with diabetes if … of an objective, impartial, comprehensive evidence-based review of the comparative effectiveness and safety … therefore performed a systematic review of published studies dealing with the comparative effectiveness and safety
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
May 01, 2009 - The DEcIDE
network assists health care providers, patients, and policymakers seeking unbiased information … Notably, while raising some concerns about off-label use, the studies
also identify disease- and patient-specific … Three prior studies have examined off-label use among broader, more representative
patient populations … insure that the most common
drugs dispensed through pharmacies matched those reported by physicians at patient … Regulatory and
reimbursement issues in treating patients
with immune-mediated neuropathies.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
December 11, 2012 - effectiveness and safety differ? … and safety differ? … and safety differ? … acute coronary syndrome a
meta-analysis of individual patient data. … followed by an
infusion of 1.75
mg/kg/hr (if CrCl< 30
ml/min reduce
infusion to 1.0
mg/kg/hr, if patient
-
effectivehealthcare.ahrq.gov/products/asthma-immunotherapy/research-protocol
September 14, 2016 - While the severity of disease varies between patients and over time in the same patient, asthma can be … there is clear evidence of a relationship between symptoms and exposure to an allergen to which the patient … use of medications. 32 However, many studies may not define clearly the population or characterize indicators … These measurements are simple and easy to do and provide the patient with immediate feedback with which … The activity domain contains 5 'patient-specific' questions.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/description-of-a-question-or-questions-about-a-health-care-test-or-treatment-o-in-women-with-leiomyomas-who-are-candidates-for-surgery-does-the-use-of-adjunctive-medical-treatment-result-in-better-outcomes-preoperative-adjuva
June 03, 2014 - In women with fibroids, what is the safety and efficacy of laparoscopic myomectomy compared with vaginal … Treatments for comparison:
Different routes of myomectomy and hysterectomy
Efficacy and safety of … contraceptive steroids, NSAIDs, GnRH agonists, aromatase inhibitors, and progesterone modulators
Relevant patients … Relevant patients: Women with a diagnosis of leiomyomas. … equipped to make appropriate management decisions for leiomyomas based on the needs of the individual patient
-
effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
October 01, 2007 - Lohr, PhD
Background: Interest in new methods for comparative effective-
ness, drug and patient safety … Key Words: comparative effectiveness, drug safety, health care,
methods, patient safety, pharmaceuticals … For decades, researchers have used Medicaid data for
research on the initiation, continuation, and patient … Methodologic challenges to studying patient safety and
comparative effectiveness. … Developing indicators of
inpatient adverse drug events through nonlinear analysis using admin-
istrative